Literature DB >> 6509038

Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum.

K Barr, R A Laine, R L Lester.   

Abstract

From the yeast phase of the human pathogen Histoplasma capsulatum, three novel glycolipids were isolated, shown to react with sera from histoplasmosis patients, and partially characterized: compound V, ceramide-P-inositol-[mannose2]; compound VI, ceramide-P-inositol-[mannose2, galactose]; compound VIII, an isomer of compound VI [Barr, K., & Lester, R.L. (1984) Biochemistry (preceding paper in this issue)]. Ammonolysis of these lipids has yielded all the carbohydrate (oligosaccharides V, VI, and VIII) as novel, intact oligosaccharides suitable for characterization. Anomeric configurations were determined by specific glycosidase digestion and by the stability of peracetylated saccharides to CrO3 oxidation. Linkages were established by methylation analysis. These experiments yielded the following structural assignments: (formula; see text) The occurrence of galactofuranose is novel for glycosphingolipids, and it is noteworthy that compound VI is immunoreactive.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6509038     DOI: 10.1021/bi00318a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Role of sphingolipids in microbial pathogenesis.

Authors:  Lena J Heung; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Sphingolipid long-chain-base auxotrophs of Saccharomyces cerevisiae: genetics, physiology, and a method for their selection.

Authors:  W J Pinto; B Srinivasan; S Shepherd; A Schmidt; R C Dickson; R L Lester
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

3.  Eukaryotic UDP-galactopyranose mutase (GLF gene) in microbial and metazoal pathogens.

Authors:  Stephen M Beverley; Katherine L Owens; Melissa Showalter; Cara L Griffith; Tamara L Doering; Victoria C Jones; Michael R McNeil
Journal:  Eukaryot Cell       Date:  2005-06

4.  Isolation and characterization of inositol sphingophospholipids from Phytophthora parasitica Dastur.

Authors:  M Bruneteau; F Fournol; C Gandon; M Becchi; V Pivot
Journal:  Lipids       Date:  1997-04       Impact factor: 1.880

5.  Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manpalpha1-->3Manpalpha1-->2IPC.

Authors:  Marcos S Toledo; Loriane Tagliari; Erika Suzuki; Claudinei M Silva; Anita H Straus; Helio K Takahashi
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

6.  Inhibition of murine macrophage protein kinase C activity by nonviable Histoplasma capsulatum.

Authors:  J E Wolf; S E Massof; J R Sherwin; R V Considine
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

7.  Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones.

Authors:  G S Deepe; J G Smith; G Sonnenfeld; D Denman; W E Bullock
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

8.  Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' disease.

Authors:  Michelle Oppenheimer; Ana L Valenciano; Pablo Sobrado
Journal:  Enzyme Res       Date:  2011-05-25

9.  Surface architecture of histoplasma capsulatum.

Authors:  Allan J Guimarães; Mariana D de Cerqueira; Joshua D Nosanchuk
Journal:  Front Microbiol       Date:  2011-11-18       Impact factor: 5.640

10.  Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages.

Authors:  W E Bullock; S D Wright
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.